Ocean Biomedical, Inc.
NASDAQ:OCEA
0.0105 (USD) • At close May 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0.026 | -0.017 | 0.305 | 0.028 | 0.393 | 0 | 1.858 | 3.192 | 3.198 | 3.194 | 2.662 | 2.664 | 25.413 | 0 | 0 |
| General & Administrative Expenses
| 1.753 | 0.768 | 0.682 | 0.569 | -0.643 | 2.35 | 2.652 | 4.83 | 0 | 1.315 | 3.708 | 1.912 | 4.984 | 2.226 | 2.676 | 18.526 | 0.835 | 0.012 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.055 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.753 | 0.768 | 0.682 | 0.569 | -0.643 | 2.35 | 2.652 | 4.83 | 0.614 | 1.37 | 3.708 | 1.912 | 4.984 | 2.226 | 2.676 | 18.526 | 0.835 | 0.012 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | -0.001 | -12.677 | 0 | 0.001 | -0.699 | 0.001 | 0 | 0.002 | 0 | 0 | 0.049 | 0 |
| Operating Expenses
| 1.753 | 0.768 | 0.682 | 0.595 | -0.66 | 2.655 | 2.68 | 5.223 | 0.614 | 1.37 | 6.9 | 5.11 | 8.178 | 4.888 | 5.34 | 43.939 | 0.884 | 0.012 |
| Operating Income
| 2.045 | -0.768 | -0.682 | -0.595 | 0.66 | -2.655 | -2.68 | -5.223 | -0.614 | -1.37 | -6.9 | -5.11 | -8.178 | -4.888 | -5.34 | -43.939 | -0.884 | -0.012 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 4.417 | -4.76 | -16.552 | 13.594 | -17.516 | -11.432 | -8.599 | -66.705 | 1.024 | 2.155 | -0.433 | -0.265 | 0 | 0.002 | -0.001 | 0 | -0.001 | 0 |
| Income Before Tax
| 6.462 | -5.528 | -17.234 | 12.999 | -16.856 | -14.087 | -13.028 | -67.401 | 0.41 | -1.018 | -7.333 | -5.375 | -8.178 | -4.886 | -5.341 | -43.939 | -0.885 | -0.012 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -3.301 | 0 | 0 | 0 | 0 | 0 | 0.668 | 60.635 | -0.055 | -0.027 | 0.433 | -0.001 | -0.069 | -0.002 | 0.001 | -0.055 | 0.001 | -0.047 |
| Net Income
| 6.462 | -5.528 | -17.234 | 12.999 | -16.856 | -14.087 | -13.028 | -128.036 | 0.41 | -1.018 | -7.766 | -5.374 | -8.178 | -4.884 | -5.342 | -43.939 | -0.886 | -0.012 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.01 | -0.2 | -0.63 | 0.48 | 0 | -0.53 | -0.49 | -5.16 | 0.031 | -0.077 | -0.73 | -0.27 | -3.1 | -0.36 | -0.4 | -1.35 | -0.044 | -0 |
| EPS Diluted
| 0.01 | -0.2 | -0.63 | 0.48 | 0 | -0.53 | -0.49 | -5.16 | 0.031 | -0.077 | -0.73 | -0.27 | -3.1 | -0.36 | -0.4 | -1.35 | -0.044 | -0 |
| EBITDA
| 0.716 | -5.067 | -16.719 | 13.636 | -16.356 | -13.794 | -10.763 | -71.791 | 15.292 | -3.607 | -7.284 | -5.359 | -8.178 | -4.888 | -5.34 | -43.939 | -0.884 | -0.012 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |